ADD-ADHD
ADHD affects an estimated 3% to 5% of children and adults in the U.S. Get ADD and ADHD information here including its causes, diagnosis, and promising treatments.
www.webmd.comHere are the latest ADHD news highlights from credible outlets up to early 2026, with quick takeaways and where to read more.
Key developments
- ADHD prevalence and diagnosis: Latest guidance continues to emphasize stable prevalence worldwide, with improvements in diagnostic tools and screening helping identify cases earlier, rather than a sudden rise in new diagnoses. This reframes public discourse around ADHD as being driven by better awareness and assessment methods rather than an epidemic. Read more from ADDitude’s year-in-review on 2025 ADHD news and research headlines.[1]
- Medication and outcomes: A body of research highlights that initiating ADHD medication within a few months of diagnosis is associated with lower risks of adverse outcomes, including suicidality and certain risky behaviors, underscoring the importance of timely treatment discussions with clinicians. See ADDitude’s coverage of medication-related findings and related studies.[1]
- Safety in pregnancy and offspring outcomes: Several reviews and studies have reinforced that commonly used ADHD medications have specific safety profiles in pregnancy, with ongoing evaluation of risks and benefits in collaboration with clinicians. CBS News and CHADD-related updates summarize evolving data and clinical recommendations.[4][1]
- Comorbidity and genetics: Research ongoing in adult ADHD, including genetic and data-science approaches, continues to refine understanding of ADHD in adulthood and its overlap with other neurodevelopmental and psychiatric conditions. See CHADD’s ADHD in the News 2025-09-04 feature for a focused look at genetics-driven insights.[4]
- Public health context: Media coverage remains broad, with outlets highlighting the broader implications of ADHD—life expectancy considerations, comorbidities, and the importance of evidence-based treatment decisions. WebMD and ScienceDaily offer accessible summaries of new findings and ongoing debates.[5][6]
What to read next
- For a curated, comprehensive roundup of 2025 ADHD news and research headlines, start with ADDitude’s annual summary. It compiles multiple studies and editorial perspectives in one place.[1]
- If you want quick, current updates from major outlets, the CBS News ADHD page presents recent studies and expert commentary.[2]
- To explore UK-focused reporting and policy discussions on ADHD services and overdiagnosis debates, ITV News ADHD coverage provides a current perspective.[3]
- For ongoing educational resources and advocacy perspectives, CHADD’s ADHD in the News and adult ADHD segments offer expert- and patient-facing insights.[10][4]
Notes on interpretation
- Readers should consider that ADHD news often centers on new research findings, treatment safety, and service delivery. Always consult a clinician for medical decisions and consider local guidelines and drug approvals, which can vary by country and over time. The sources above reflect multiple jurisdictions and should be cross-checked with local medical guidance.
Would you like me to pull the most recent articles from specific outlets (e.g., ADDitude, WebMD, CHADD) and summarize the top 5 with links? I can also tailor a brief briefing for Prague-based considerations or healthcare contexts.